Leveraging phased variants for personalized minimal residual disease detection in localized non-small cell lung cancer. Kurtz, D., Chabon, J. J., Sworder, B., Keh, L., Soo, J., Alig, S., Schultz, A., Garofalo, A., Hamilton, E. G., Chen, B., Olsen, M., Moding, E., Liu, C., Alizadeh, A. A., Diehn, M. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.8518

View details for Web of Science ID 000708120604232